Loading…
Reported covered position: Senior Legislative Assistant/ Legislative Assistant, Congressman John J. Duncan, Jr.; Senior Campaign Finance Analyst/ Campaign Finance Analyst, Federal Election Commission
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Event Contract Enforcement Act
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Support for HR7840 (Event Contract Enforcement Act) addressing event contracts on war, etc. (recognizing such activity as gambling, a common addictive activity).
Event Contract Enforcement Act
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Support for HR7840 (Event Contract Enforcement Act) addressing event contracts on war, etc. (recognizing such activity as gambling, a common addictive activity).
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BENCH IN A BOX TECHNOLOGIES via TENAGRITY SOLUTIONS, LLC
2026 · third_quarter · 3T
Bench in a Box Technologies is developing a unique "handheld lab"; raising general awareness amongst Dept of War, HHS (specifically only BARDA, FDA), and health policy staffers in Congress; preparing for FY28 appropriations.
Bench in a Box Technologies is developing a unique "handheld lab"; raising general awareness amongst Dept of War, HHS (specifically only BARDA, FDA), and health policy staffers in Congress; preparing for FY28 appropriations.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Source: Senate LDA
| 1DAY SOONER |
| 3 |
| 2023 |
| CBA PHARMA INC. | 3 | 2025–2026 |
| UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER | 3 | 2024 |
| BENCH IN A BOX TECHNOLOGIES | 2 | 2026 |
Event Contract Enforcement Act
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Support for HR7840 (Event Contract Enforcement Act) addressing event contracts on war, etc. (recognizing such activity as gambling, a common addictive activity).
Event Contract Enforcement Act
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Support for HR7840 (Event Contract Enforcement Act) addressing event contracts on war, etc. (recognizing such activity as gambling, a common addictive activity).
Event Contract Enforcement Act
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Support for HR7840 (Event Contract Enforcement Act) addressing event contracts on war, etc. (recognizing such activity as gambling, a common addictive activity).
Event Contract Enforcement Act
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Support for HR7840 (Event Contract Enforcement Act) addressing event contracts on war, etc. (recognizing such activity as gambling, a common addictive activity).
Department of Defense Appropriations Act, 2026
Client: EMIT CORPORATION · Firm: TENAGRITY SOLUTIONS, LLC
Outreach to DoD regarding potential opportunities for contracts for EMIT's exceptional equipment in freezing conditions. Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense), specifically FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296)
Department of Defense Appropriations Act, 2026
Client: EMIT CORPORATION · Firm: TENAGRITY SOLUTIONS, LLC
Outreach to DoD regarding potential opportunities for contracts for EMIT's exceptional equipment in freezing conditions. Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense), specifically FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296)
Department of Defense Appropriations Act, 2026
Client: KARDIOGENICS, INC. · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296), requests to ensure adequate funding to finalize development and distribution
Department of Defense Appropriations Act, 2026
Client: KARDIOGENICS, INC. · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 defense appropriations (H.R.4016), requests to ensure adequate funding to finalize development and distribution
Department of Defense Appropriations Act, 2026
Client: KARDIOGENICS, INC. · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 defense appropriations (H.R.4016) requests to ensure adequate funding to finalize development and distribution
Department of Defense Appropriations Act, 2026
Client: KARDIOGENICS, INC. · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296), requests to ensure adequate funding to finalize development and distribution
Department of Defense Appropriations Act, 2026
Client: KARDIOGENICS, INC. · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296), requests to ensure adequate funding to finalize development and distribution
Department of Defense Appropriations Act, 2026
Client: KARDIOGENICS, INC. · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296), requests to ensure adequate funding to finalize development and distribution
Department of Defense Appropriations Act, 2026
Client: EMIT CORPORATION · Firm: TENAGRITY SOLUTIONS, LLC
Outreach to DoD regarding potential opportunities for contracts for EMIT's exceptional equipment in freezing conditions. Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense), specifically FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296).
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access (for veterans and others) as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
House and Senate FY26 appropriations bills (Ag-FDA: S.2256, H.R. 4121) and NDAA S. 2296 (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access (for veterans and others) as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access (for veterans and others) as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Pandemic and All-Hazards Preparedness and Response Act (PAHPA) and Prescription Drug User Fee Act (PDUFA) and House and Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Support for Sen. Cassidy's anticipated HEP-C elimination legislation (including specifically clinical trial research). Communication with congressional offices re: enabling greater use of human challenge studies. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Pandemic and All-Hazards Preparedness and Response Act (PAHPA) and Prescription Drug User Fee Act (PDUFA) and House and Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Support for Sen. Cassidy's anticipated HEP-C elimination legislation (including specifically clinical trial research). Communication with congressional offices re: enabling greater use of human challenge studies. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Pandemic and All-Hazards Preparedness and Response Act (PAHPA) and Prescription Drug User Fee Act (PDUFA) and House and Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Support for Sen. Cassidy's anticipated HEP-C elimination legislation (including specifically clinical trial research). Communication with congressional offices re: enabling greater use of human challenge studies. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Discussions with the HHS and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
House and Senate FY26 appropriations bills (Ag-FDA: S.2256, H.R. 4121) and NDAA S. 2296 (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296).
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
House and Senate FY26 appropriations bills (L-HHS, H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access (for veterans and others) as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access (for veterans and others) as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
House and Senate FY26 appropriations bills (Ag-FDA: S.2256, H.R. 4121) and NDAA S. 2296 (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
House and Senate FY26 appropriations bills (Ag-FDA: S.2256, H.R. 4121) and NDAA S. 2296 (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Pandemic and All-Hazards Preparedness and Response Act (PAHPA) and Prescription Drug User Fee Act (PDUFA) and House and Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Support for Sen. Cassidy's anticipated HEP-C elimination legislation (including specifically clinical trial research). Communication with congressional offices re: enabling greater use of human challenge studies. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Discussions with the HHS and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Pandemic and All-Hazards Preparedness and Response Act (PAHPA) and Prescription Drug User Fee Act (PDUFA) and House and Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Support for Sen. Cassidy's anticipated HEP-C elimination legislation (including specifically clinical trial research). Communication with congressional offices re: enabling greater use of human challenge studies. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Pandemic and All-Hazards Preparedness and Response Act (PAHPA) and Prescription Drug User Fee Act (PDUFA) and House and Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Support for Sen. Cassidy's anticipated HEP-C elimination legislation (including specifically clinical trial research). Communication with congressional offices re: enabling greater use of human challenge studies. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access (for veterans and others) as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296).
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
Client: CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
National Defense Authorization Act for Fiscal Year 2026
Client: KARDIOGENICS, INC. · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296), requests to ensure adequate funding to finalize development and distribution
National Defense Authorization Act for Fiscal Year 2026
Client: KARDIOGENICS, INC. · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296), requests to ensure adequate funding to finalize development and distribution
National Defense Authorization Act for Fiscal Year 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well).
National Defense Authorization Act for Fiscal Year 2026
Client: EMIT CORPORATION · Firm: TENAGRITY SOLUTIONS, LLC
Outreach to DoD regarding potential opportunities for contracts for EMIT's exceptional equipment in freezing conditions. Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense), specifically FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296)
National Defense Authorization Act for Fiscal Year 2026
Client: EMIT CORPORATION · Firm: TENAGRITY SOLUTIONS, LLC
Outreach to DoD regarding potential opportunities for contracts for EMIT's exceptional equipment in freezing conditions. Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense), specifically FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296)
National Defense Authorization Act for Fiscal Year 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296)
National Defense Authorization Act for Fiscal Year 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296).
National Defense Authorization Act for Fiscal Year 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
National Defense Authorization Act for Fiscal Year 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
National Defense Authorization Act for Fiscal Year 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
National Defense Authorization Act for Fiscal Year 2026
Client: EMIT CORPORATION · Firm: TENAGRITY SOLUTIONS, LLC
Outreach to DoD regarding potential opportunities for contracts for EMIT's exceptional equipment in freezing conditions. Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense), specifically FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296)
National Defense Authorization Act for Fiscal Year 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
House and Senate FY26 appropriations bills (Ag-FDA: S.2256, H.R. 4121) and NDAA S. 2296 (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health
National Defense Authorization Act for Fiscal Year 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
House and Senate FY26 appropriations bills (Ag-FDA: S.2256, H.R. 4121) and NDAA S. 2296 (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health
National Defense Authorization Act for Fiscal Year 2026
Client: KARDIOGENICS, INC. · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296), requests to ensure adequate funding to finalize development and distribution
National Defense Authorization Act for Fiscal Year 2026
Client: KARDIOGENICS, INC. · Firm: TENAGRITY SOLUTIONS, LLC
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296), requests to ensure adequate funding to finalize development and distribution
National Defense Authorization Act for Fiscal Year 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296).
National Defense Authorization Act for Fiscal Year 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
National Defense Authorization Act for Fiscal Year 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296)
National Defense Authorization Act for Fiscal Year 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296).
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
House and Senate FY26 appropriations bills (L-HHS, H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with pursuing a letter of support from the Senate to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and strengthen interagency relationships for national security and emerging pathogen / pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with the WH, HHS, and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives Interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with congressional letter(s) of support to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines Discussions with the WH, HHS, and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Interactions with Congress and the WH, HHS, and DoD to promote prompt distribution of malaria vaccines Discussions with the WH, HHS, and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with pursuing a letter of support from the Senate to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Interactions with Congress and the WH, HHS, and DoD to promote prompt distribution of malaria vaccines Discussions with the WH, HHS, and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and strengthen interagency relationships for national security and emerging pathogen / pandemic preparedness (HR9027, HR9029; S4638; S4690). To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives Interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with congressional letter(s) of support to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines Discussions with the WH, HHS, and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and strengthen interagency relationships for national security and emerging pathogen / pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with the WH, HHS, and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives Interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025
Client: 1DAY SOONER ACTION PROJECT · Firm: TENAGRITY SOLUTIONS, LLC
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with congressional letter(s) of support to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines Discussions with the WH, HHS, and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
SOTER BIO INC. via TENAGRITY SOLUTIONS, LLC
2026 · third_quarter · 3T
Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity. Arranging DoW CBRN visit to facility.
Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity. Arranging DoW CBRN visit to facility.
Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity. Arranging DoW CBRN visit to facility.
Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity, critical for disaster preparedness
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH via TENAGRITY SOLUTIONS, LLC
2026 · third_quarter · 3T
Support for HR7840 (Event Contract Enforcement Act) addressing event contracts on war, etc. (recognizing such activity as gambling, a common addictive activity).
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD; potential legislation to create a SUD PRV to increase development of and access to new SUD medicines; support for the FDA Commissioners national PRV and related pathways; support for NIH high-impact clinical trials evaluating repuposed off-patent therapeutics and widely used supplements with potential CMMI involvement; support for White House and CMMI exploration of non-opioid acute pain therapeutics. Related language requests in FY27 L-HHS and Ag-FDA appropriations. Related potential legislation (discussions particularly with Rep. Cline, Auchincloss, and Harder).
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD; potential legislation to create a SUD PRV to increase development of and access to new SUD medicines; support for the FDA Commissioners national PRV and related pathways; support for NIH high-impact clinical trials evaluating repuposed off-patent therapeutics and widely used supplements with potential CMMI involvement; support for White House and CMMI exploration of non-opioid acute pain therapeutics. Related language requests in FY27 L-HHS and Ag-FDA appropriations. Related potential legislation (discussions particularly with Rep. Cline, Auchincloss, and Harder).
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD; potential legislation to create a SUD PRV to increase development of and access to new SUD medicines; support for the FDA Commissioners national PRV and related pathways; support for NIH high-impact clinical trials evaluating repuposed off-patent therapeutics and widely used supplements with potential CMMI involvement; support for White House and CMMI exploration of non-opioid acute pain therapeutics. Related language requests in FY27 L-HHS and Ag-FDA appropriations. Related potential legislation (discussions particularly with Rep. Cline, Auchincloss, and Harder).
Support for HR7840 (Event Contract Enforcement Act) addressing event contracts on war, etc. (recognizing such activity as gambling, a common addictive activity).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
1DAY SOONER ACTION PROJECT via TENAGRITY SOLUTIONS, LLC
2026 · third_quarter · 3T
Requested report language for increased use of human challenge studies and HHS integration of privacy-preserving health data discovery and search tools in FY27 L-HHS and Ag-FDA appropriations legislation.
Prioritization of improved indoor air quality federal facilities to promote health (additional legislation on this topic). FDA reforms including maximized use of AI, improved use of Sentinel, improved IRB processes, and related reforms; working with Rep. Auchincloss, Cline, Griffith, Harder, and Sen Hickenlooper offices to draft legislation. Requested related report language for these issues as well as increased use of human challenge studies and HHS integration of privacy-preserving health data discovery and search tools in FY27NDAA and FY27 Defense, L-HHS, and Ag-FDA appropriations legislation.
Prioritization of improved indoor air quality in military and other federal facilities to promote health. Requested related report language in FY27NDAA and FY27 Defense, L-HHS, and Ag-FDA appropriations legislation.
Prioritization of improved indoor air quality in military and other federal facilities to promote health. Requested related report language in FY27NDAA and FY27 Defense appropriations legislation.
Prioritization of improved indoor air quality federal facilities to promote health (additional legislation on this topic). FDA reforms including maximized use of AI, improved use of Sentinel, improved IRB processes, and related reforms; working with Rep. Auchincloss, Cline, Griffith, Harder, and Sen Hickenlooper offices to draft legislation. Requested related report language for these issues as well as increased use of human challenge studies and HHS integration of privacy-preserving health data discovery and search tools in FY27NDAA and FY27 Defense, L-HHS, and Ag-FDA appropriations legislation.
Prioritization of improved indoor air quality federal facilities to promote health (additional legislation on this topic). FDA reforms including maximized use of AI, improved use of Sentinel, improved IRB processes, and related reforms; working with Rep. Auchincloss, Cline, Griffith, Harder, and Sen Hickenlooper offices to draft legislation. Requested related report language for these issues as well as increased use of human challenge studies and HHS integration of privacy-preserving health data discovery and search tools in FY27NDAA and FY27 Defense, L-HHS, and Ag-FDA appropriations legislation. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BENCH IN A BOX TECHNOLOGIES via TENAGRITY SOLUTIONS, LLC
2026 · second_quarter · RR
Raising awareness amongst HHS, Dept of War, and Congress of this developing technology. Preparing for FY28 Appropriations.
Raising awareness amongst HHS, Dept of War, and Congress of this developing technology. Preparing for FY28 Appropriations.
SOTER BIO INC. via TENAGRITY SOLUTIONS, LLC
2026 · second_quarter · Q2
Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity. Arranging DoW CBRN visit to facility.
Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity. Arranging DoW CBRN visit to facility.
Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity, critical for disaster preparedness
Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity. Arranging DoW CBRN visit to facility.
CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH via TENAGRITY SOLUTIONS, LLC
2026 · second_quarter · Q2
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD; potential legislation to create a SUD PRV to increase development of and access to new SUD medicines; support for the FDA Commissioners national PRV and related pathways; support for NIH high-impact clinical trials evaluating repuposed off-patent therapeutics and widely used supplements with potential CMMI involvement; support for White House and CMMI exploration of non-opioid acute pain therapeutics. Related language requests in FY27 L-HHS and Ag-FDA appropriations. Related potential legislation (discussions particularly with Rep. Cline, Auchincloss, and Harder).
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD; potential legislation to create a SUD PRV to increase development of and access to new SUD medicines; support for the FDA Commissioners national PRV and related pathways; support for NIH high-impact clinical trials evaluating repuposed off-patent therapeutics and widely used supplements with potential CMMI involvement; support for White House and CMMI exploration of non-opioid acute pain therapeutics. Related language requests in FY27 L-HHS and Ag-FDA appropriations. Related potential legislation (discussions particularly with Rep. Cline, Auchincloss, and Harder).
1DAY SOONER ACTION PROJECT via TENAGRITY SOLUTIONS, LLC
2026 · second_quarter · Q2
Prioritization of improved indoor air quality in military and other federal facilities to promote health. Requested related report language in FY27NDAA and FY27 Defense appropriations legislation.
Prioritization of improved indoor air quality in military and other federal facilities to promote health. Requested related report language in FY27NDAA and FY27 Defense, L-HHS, and Ag-FDA appropriations legislation.
Prioritization of improved indoor air quality federal facilities to promote health (additional legislation on this topic). FDA reforms including maximized use of AI, improved use of Sentinel, improved IRB processes, and related reforms; working with Rep. Auchincloss, Cline, Griffith, Harder, and Sen Hickenlooper offices to draft legislation. Requested related report language for these issues as well as increased use of human challenge studies and HHS integration of privacy-preserving health data discovery and search tools in FY27NDAA and FY27 Defense, L-HHS, and Ag-FDA appropriations legislation. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
KARDIOGENICS, INC. via TENAGRITY SOLUTIONS, LLC
2026 · second_quarter · Q2
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY27 defense appropriations and NDAA, requests to ensure adequate funding for such innovations to finalize development and distribution
Discussions with congressional offices and HHS re: client and how their product and work could save lives
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY27 defense appropriations and NDAA, requests to ensure adequate funding for such innovations to finalize development and distribution
CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH via TENAGRITY SOLUTIONS, LLC
2026 · first_quarter · Q1
Support for HR7840 (Event Contract Enforcement Act) addressing event contracts on war, etc. (recognizing such activity as gambling, a common addictive activity).
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD; potential legislation to create a SUD PRV to increase development of and access to new SUD medicines; support for the FDA Commissioners national PRV and related pathways; support for NIH high-impact clinical trials evaluating repuposed off-patent therapeutics and widely used supplements with potential CMMI involvement; support for White House and CMMI exploration of non-opioid acute pain therapeutics. Related language requests in FY27 L-HHS and Ag-FDA appropriations.
1DAY SOONER ACTION PROJECT via TENAGRITY SOLUTIONS, LLC
2026 · first_quarter · Q1
Prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Requested related report language for these issues as well as increased use of human challenge studies and HHS integration of privacy-preserving health data discovery and search tools in FY27NDAA and FY27 Defense, L-HHS, and Ag-FDA appropriations legislation. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Requested related report language for these issues as well as increased use of human challenge studies and HHS integration of privacy-preserving health data discovery and search tools in FY27NDAA and FY27 Defense, L-HHS, and Ag-FDA appropriations legislation. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
SOTER BIO INC. via TENAGRITY SOLUTIONS, LLC
2026 · first_quarter · Q1
Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity
Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity
Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity, critical for disaster preparedness
KARDIOGENICS, INC. via TENAGRITY SOLUTIONS, LLC
2026 · first_quarter · Q1
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY27 defense appropriations and NDAA, requests to ensure adequate funding for such innovations to finalize development and distribution
Discussions with congressional offices and HHS re: client and how their product and work could save lives
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY27 defense appropriations and NDAA, requests to ensure adequate funding for such innovations to finalize development and distribution
CBA PHARMA INC. via TENAGRITY SOLUTIONS, LLC
2026 · first_quarter · 1T
Raising awareness amongst DOJ officials of the company's challenges as it attempts to move forward with its drug.
Raising awareness amongst appropriate HHS officials of the company's challenges as it attempts to move forward with its drug.
Filing targets: Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ)
SOTER BIO INC. via TENAGRITY SOLUTIONS, LLC
2025 · fourth_quarter · RR
Raising awareness of Soter Bio's capabilities and potential to address a number of the nation's supply chain issues and operational readiness
Raising awareness of Soter Bio's capabilities and potential to address a number of the nation's supply chain issues and operational readiness
CBA PHARMA INC. via TENAGRITY SOLUTIONS, LLC
2025 · fourth_quarter · Q4
Raising awareness amongst appropriate HHS officials of the company's challenges as it attempts to move forward with its drug.
Raising awareness amongst DOJ officials of the company's challenges as it attempts to move forward with its drug.
Filing targets: Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ)
1DAY SOONER ACTION PROJECT via TENAGRITY SOLUTIONS, LLC
2025 · fourth_quarter · Q4
Prioritization of improved indoor air quality in military and other federal facilities to promote health
Prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well).
Prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296).
CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH via TENAGRITY SOLUTIONS, LLC
2025 · fourth_quarter · Q4
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access (for veterans and others) as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
KARDIOGENICS, INC. via TENAGRITY SOLUTIONS, LLC
2025 · fourth_quarter · Q4
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296), requests to ensure adequate funding to finalize development and distribution
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296), requests to ensure adequate funding to finalize development and distribution
SPEAR HUMAN PERFORMANCE, INC. via TENAGRITY SOLUTIONS, LLC
2025 · fourth_quarter · Q4
Discussions and communications with congressional offices re: how client's AI work could be useful to DOGE efforts to combat and prevent waste, fraud, and abuse. Discussions with DoD and HHS about additional, potential contract opportunities.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
EMIT CORPORATION via TENAGRITY SOLUTIONS, LLC
2025 · third_quarter · 3A
Outreach to DoD regarding potential opportunities for contracts for EMIT's exceptional equipment in freezing conditions. Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense), specifically FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296)
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
EMIT CORPORATION via TENAGRITY SOLUTIONS, LLC
2025 · fourth_quarter · 4T
Outreach to DoD regarding potential opportunities for contracts for EMIT's exceptional equipment in freezing conditions. Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense), specifically FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296)
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
CBA PHARMA INC. via TENAGRITY SOLUTIONS, LLC
2025 · fourth_quarter · RR
Raising awareness amongst appropriate HHS officials of the company's challenges as it attempts to move forward with its drug.
1DAY SOONER ACTION PROJECT via TENAGRITY SOLUTIONS, LLC
2025 · third_quarter · Q3
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH via TENAGRITY SOLUTIONS, LLC
2025 · third_quarter · Q3
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access (for veterans and others) as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
EMIT CORPORATION via TENAGRITY SOLUTIONS, LLC
2025 · third_quarter · Q3
Outreach to DoD regarding potential opportunities for contracts for EMIT's exceptional equipment in freezing conditions. Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense), specifically FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296)
Filing targets: Defense, Dept of (DOD)
SPEAR HUMAN PERFORMANCE, INC. via TENAGRITY SOLUTIONS, LLC
2025 · second_quarter · 2A
Discussions and communications with congressional offices and HHS (CMMI) re: how client's AI work could be useful to DOGE efforts to combat and prevent waste, fraud, and abuse.
Discussions and communications with congressional offices and HHS (CMMI) re: how client's AI work could be useful to DOGE efforts to combat and prevent waste, fraud, and abuse.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
KARDIOGENICS, INC. via TENAGRITY SOLUTIONS, LLC
2025 · third_quarter · Q3
Discussions with congressional offices, HHS, and DoD re: client and how their product and work could save lives (including how they can help with defense)
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296), requests to ensure adequate funding to finalize development and distribution
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 & FY27 defense appropriations (H.R.4016) and FY26 NDAA (S2296), requests to ensure adequate funding to finalize development and distribution
SPEAR HUMAN PERFORMANCE, INC. via TENAGRITY SOLUTIONS, LLC
2025 · third_quarter · Q3
Discussions and communications with congressional offices re: how client's AI work could be useful to DOGE efforts to combat and prevent waste, fraud, and abuse. Discussions with DoD and HHS about additional, potential contract opportunities.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
EMIT CORPORATION via TENAGRITY SOLUTIONS, LLC
2025 · second_quarter · Q2
Outreach to DoD regarding potential opportunities for contracts for EMIT's exceptional equipment in freezing conditions.
Filing targets: Defense, Dept of (DOD)
EMIT CORPORATION via TENAGRITY SOLUTIONS, LLC
2025 · second_quarter · RR
Outreach to DoD and Congressional staff regarding the company's innovative technologies and how they can be more widely used by the military to save lives
CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH via TENAGRITY SOLUTIONS, LLC
2025 · second_quarter · Q2
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access (for veterans and others) as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
1DAY SOONER ACTION PROJECT via TENAGRITY SOLUTIONS, LLC
2025 · second_quarter · Q2
Pandemic and All-Hazards Preparedness and Response Act (PAHPA) and Prescription Drug User Fee Act (PDUFA) and House and Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Support for Sen. Cassidy's anticipated HEP-C elimination legislation (including specifically clinical trial research). Communication with congressional offices re: enabling greater use of human challenge studies. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Pandemic and All-Hazards Preparedness and Response Act (PAHPA) and Prescription Drug User Fee Act (PDUFA) and House and Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Support for Sen. Cassidy's anticipated HEP-C elimination legislation (including specifically clinical trial research). Communication with congressional offices re: enabling greater use of human challenge studies. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
KARDIOGENICS, INC. via TENAGRITY SOLUTIONS, LLC
2025 · second_quarter · Q2
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 defense appropriations (H.R.4016), requests to ensure adequate funding to finalize development and distribution
Discussions with congressional offices and HHS re: client and how their product and work could save lives
Discussions with congressional offices, HHS, and DoD re: client and how their product and work could save lives (including how they can help with defense)
SPEAR HUMAN PERFORMANCE, INC. via TENAGRITY SOLUTIONS, LLC
2025 · second_quarter · Q2
Discussions and communications with congressional offices re: how client's AI work could be useful to DOGE efforts to combat and prevent waste, fraud, and abuse. Discussions with DoD about additional, potential contract opportunities.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES
KARDIOGENICS, INC. via TENAGRITY SOLUTIONS, LLC
2025 · first_quarter · Q1
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 defense appropriations requests to ensure adequate funding to finalize development and distribution
Discussions with congressional offices and HHS re: client and how their product and work could save lives
Discussions with congressional offices, HHS, and DoD re: client and how their product and work could save lives (including how they can help with defense)
1DAY SOONER ACTION PROJECT via TENAGRITY SOLUTIONS, LLC
2025 · first_quarter · 1A
Pandemic and All-Hazards Preparedness and Response Act (PAHPA) and Prescription Drug User Fee Act (PDUFA) and House and Senate FY26 appropriations bills (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA); FDA reforms including maximized use of AI. Support for Sen. Cassidy's anticipated HEP-C elimination legislation (including specifically clinical trial research). Communication with congressional offices re: enabling greater use of human challenge studies. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Discussions with the HHS and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
1DAY SOONER ACTION PROJECT via TENAGRITY SOLUTIONS, LLC
2025 · first_quarter · 1A
Pandemic and All-Hazards Preparedness and Response Act (PAHPA) and Prescription Drug User Fee Act (PDUFA) and House and Senate FY26 appropriations bills (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA); FDA reforms including maximized use of AI. Support for Sen. Cassidy's anticipated HEP-C elimination legislation (including specifically clinical trial research). Communication with congressional offices re: enabling greater use of human challenge studies. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Discussions with the HHS and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH via TENAGRITY SOLUTIONS, LLC
2025 · first_quarter · Q1
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines.
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access (for veterans and others) as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines.
1DAY SOONER ACTION PROJECT via TENAGRITY SOLUTIONS, LLC
2025 · first_quarter · Q1
Pandemic and All-Hazards Preparedness and Response Act (PAHPA) and Prescription Drug User Fee Act (PDUFA) and House and Senate FY26 appropriations bills (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA); FDA reforms including maximized use of AI. Support for Sen. Cassidy's anticipated HEP-C elimination legislation (including specifically clinical trial research). Communication with congressional offices re: enabling greater use of human challenge studies. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Discussions with the HHS and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
SPEAR HUMAN PERFORMANCE, INC. via TENAGRITY SOLUTIONS, LLC
2025 · first_quarter · Q1
Discussions and communications with congressional offices re: how client's AI work could be useful to DOGE efforts to combat and prevent waste, fraud, and abuse.
Filing targets: HOUSE OF REPRESENTATIVES
CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH via TENAGRITY SOLUTIONS, LLC
2024 · fourth_quarter · Q4
Discussions with / outreach to (and/or preparation for such outreach) VA, Congressional offices, and HHS officials re: potential avenues to increase GLP-1 access to veterans and others as a method of substance use disorder treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; discussions re: VA study of impact of GLP-1s on SUDs.
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access to veterans and others as a method of substance use disorder treatment and other potential strategies for increasing innovation and the development of improved addiction medicines
KARDIOGENICS, INC. via TENAGRITY SOLUTIONS, LLC
2024 · fourth_quarter · Q4
Discussions with congressional offices and DoD re: client and how their product and work (including how they can help with defense)
Discussions with congressional offices and DoD re: client and how their product and work (including how they can help with defense)
Discussions with congressional offices and DoD re: client and how their product and work (including how they can help with defense)
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
1DAY SOONER ACTION PROJECT via TENAGRITY SOLUTIONS, LLC
2024 · third_quarter · 3A
House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and strengthen interagency relationships for national security and emerging pathogen / pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with the WH, HHS, and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives Interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with congressional letter(s) of support to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines Discussions with the WH, HHS, and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
1DAY SOONER ACTION PROJECT via TENAGRITY SOLUTIONS, LLC
2024 · fourth_quarter · Q4
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Interactions with Congress and the WH, HHS, and DoD to promote prompt distribution of malaria vaccines Discussions with the WH, HHS, and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Interactions with Congress and the WH, HHS, and DoD to promote prompt distribution of malaria vaccines Discussions with the WH, HHS, and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER via TENAGRITY SOLUTIONS, LLC
2024 · third_quarter · Q3
Meetings / interactions with HHS and congressional offices - to increase federal government awareness of client's groundbreaking medical research and in preparation for grant proposal(s)
Meetings / interactions with HHS and congressional offices - to increase federal government awareness of client's groundbreaking medical research and in preparation for grant proposal(s)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
1DAY SOONER ACTION PROJECT via TENAGRITY SOLUTIONS, LLC
2024 · third_quarter · Q3
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with congressional letter(s) of support to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines Discussions with the WH, HHS, and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and strengthen interagency relationships for national security and emerging pathogen / pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with the WH, HHS, and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives Interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines
CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH via TENAGRITY SOLUTIONS, LLC
2024 · third_quarter · Q3
Discussions with / outreach to Congressional offices and HHS officials re: potential avenues to increase GLP-1 access to veterans and others as a method of substance use disorder treatment and other potential strategies for increasing resources devoted to the development of improved addiction medicines.
Discussions with / outreach to Congressional offices and prep for mtgs with VA officials re: potential avenues to increase GLP-1 access to veterans and others as a method of substance use disorder treatment and other potential strategies for increasing resources devoted to the development of improved addiction medicines.
KARDIOGENICS, INC. via TENAGRITY SOLUTIONS, LLC
2024 · third_quarter · Q3
Discussions with congressional offices and DoD re: client and how their product and work (including how they can help with defense); meetings with FDA officials re: approval for client's product
Discussions with congressional offices and DoD re: client and how their product and work (including how they can help with defense); meetings with FDA officials re: approval for client's product
Discussions with congressional offices and DoD re: client and how their product and work (including how they can help with defense); meetings with FDA officials re: approval for client's product
SPEAR HUMAN PERFORMANCE, INC. via TENAGRITY SOLUTIONS, LLC
2024 · third_quarter · Q3
Discussion of client with congressional offices re: how their defense and other work can help the health care industry
Discussion of client with congressional offices re: how their defense and other work can help the health care industry
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER via TENAGRITY SOLUTIONS, LLC
2024 · second_quarter · Q2
Meetings with HHS and congressional offices - to increase federal government awareness of client's groundbreaking medical research and in preparation for grant proposal(s)
Meetings with HHS and congressional offices - to increase federal government awareness of client's groundbreaking medical research and in preparation for grant proposal(s)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
1DAY SOONER ACTION PROJECT via TENAGRITY SOLUTIONS, LLC
2024 · second_quarter · 2A
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with pursuing a letter of support from the Senate to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with pursuing a letter of support from the Senate to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH via TENAGRITY SOLUTIONS, LLC
2024 · third_quarter · RR
Exploring how to collaborate with the federal government (such as VA and DoD) to advance better medical therapies for addiction
Exploring how to collaborate with the federal government (such as VA and DoD) to advance better medical therapies for addiction
Exploring how to collaborate with the federal government (such as VA and DoD) to advance better medical therapies for addiction
1DAY SOONER ACTION PROJECT via TENAGRITY SOLUTIONS, LLC
2024 · second_quarter · Q2
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with pursuing a letter of support from the Senate to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and strengthen interagency relationships for national security and emerging pathogen / pandemic preparedness. To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives Interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines
KARDIOGENICS, INC. via TENAGRITY SOLUTIONS, LLC
2024 · second_quarter · Q2
Discussions with congressional offices and DoD re: client and how their product and work (including how they can help with defense); meetings with FDA officials re: approval for client's product
Discussions with congressional offices and DoD re: client and how their product and work (including how they can help with defense); meetings with FDA officials re: approval for client's product
Discussions with congressional offices and DoD re: client and how their product and work (including how they can help with defense); meetings with FDA officials re: approval for client's product
SPEAR HUMAN PERFORMANCE, INC. via TENAGRITY SOLUTIONS, LLC
2024 · second_quarter · Q2
Introduction of client to congressional offices re: how their defense and other work can help the health care industry
Introduced client to congressional offices re: how their defense and other work can help the health care industry
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER via TENAGRITY SOLUTIONS, LLC
2024 · second_quarter · RR
Assistance with pursuing federal funding; raising awareness of the Center's medical research with government officials (legislative and/or executive branch).
Assistance with pursuing federal funding; raising awareness of the Center's medical research with government officials (legislative and/or executive branch).
Assistance with pursuing federal funding; raising awareness of the Center's medical research with government officials (legislative and/or executive branch).
1DAY SOONER ACTION PROJECT via TENAGRITY SOLUTIONS, LLC
2024 · first_quarter · Q1
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); FY24 & FY25 appropriations to ensure adequate resources for HHS for pandemic preparedness. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with a letter of support to HHS, encouraging the establishment of an emerging pathogen preparedness program through the FDA Assistance with a letter of support from the US House (and pursuing one from the Senate) to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines . To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives Interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines
KARDIOGENICS, INC. via TENAGRITY SOLUTIONS, LLC
2024 · first_quarter · Q1
Preparation to introduce client to congressional offices re: how their health work can help with defense
Preparation to introduce client to congressional offices re: how their health work can help with defense
Preparation to introduce client to congressional offices re: how their health work can help with defense
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPEAR HUMAN PERFORMANCE, INC. via TENAGRITY SOLUTIONS, LLC
2024 · first_quarter · Q1
Introduction of client to congressional offices re: how their defense and other work can help the health care industry
Introduced client to congressional offices re: how their defense and other work can help the health care industry
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
1DAY SOONER ACTION PROJECT via TENAGRITY SOLUTIONS, LLC
2024 · first_quarter · RR
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with a letter of support to HHS, encouraging the establishment of an emerging pathogen preparedness program through the FDA. To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with a letter of support to HHS, encouraging the establishment of an emerging pathogen preparedness program through the FDA. To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
KARDIOGENICS, INC. via TENAGRITY SOLUTIONS, LLC
2023 · fourth_quarter · Q4
Preparation to introduce client to congressional offices re: how their health work can help with defense
Preparation to introduce client to congressional offices re: how their health work can help with defense
Preparation to introduce client to congressional offices re: how their health work can help with defense
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPEAR HUMAN PERFORMANCE, INC. via TENAGRITY SOLUTIONS, LLC
2023 · fourth_quarter · Q4
Preparation to introduce client to congressional offices re: how their defense work can help the health care industry
Preparation to introduce client to congressional offices re: how their defense work can help the health care industry
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
1DAY SOONER via TENAGRITY SOLUTIONS, LLC
2023 · fourth_quarter · 4T
To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with a letter of support to HHS, encouraging the establishment of an emerging pathogen preparedness program through the FDA. To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
KARDIOGENICS, INC. via TENAGRITY SOLUTIONS, LLC
2023 · fourth_quarter · RR
Assistance with pursuing HHS and/or DoD contracts; raising awareness of the company with gov't officials (legislative and/or executive branch)
Assistance with pursuing HHS and/or DoD contracts; raising awareness of the company with gov't officials (legislative and/or executive branch)
Assistance with pursuing HHS and/or DoD contracts; raising awareness of the company with gov't officials (legislative and/or executive branch)
SPEAR HUMAN PERFORMANCE, INC. via TENAGRITY SOLUTIONS, LLC
2023 · fourth_quarter · RR
Assistance with securing government HHS and/or DoD contracts and raising awareness of client's capabilities
Assistance with securing government HHS and/or DoD contracts and raising awareness of client's capabilities
1DAY SOONER via TENAGRITY SOLUTIONS, LLC
2023 · third_quarter · Q3
To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA). Assistance with a letter of support to HHS, encouraging the establishment of an emerging pathogen preparedness program through the FDA. To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
1DAY SOONER via TENAGRITY SOLUTIONS, LLC
2023 · third_quarter · RR
funding for the FDA, Project Next Gen, and medical research; specific legislation includes S2329 and PAHPA.
funding for the FDA, Project Next Gen, and medical research; specific legislation includes S2329 and PAHPA.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Support for HR7840 (Event Contract Enforcement Act) addressing event contracts on war, etc. (recognizing such activity as gambling, a common addictive activity).
Support for HR7840 (Event Contract Enforcement Act) addressing event contracts on war, etc. (recognizing such activity as gambling, a common addictive activity).
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD; potential legislation to create a SUD PRV to increase development of and access to new SUD medicines; support for the FDA Commissioners national PRV and related pathways; support for NIH high-impact clinical trials evaluating repuposed off-patent therapeutics and widely used supplements with potential CMMI involvement; support for White House and CMMI exploration of non-opioid acute pain therapeutics. Related language requests in FY27 L-HHS and Ag-FDA appropriations. Related potential legislation (discussions particularly with Rep. Cline, Auchincloss, and Harder).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Prioritization of improved indoor air quality federal facilities to promote health (additional legislation on this topic). FDA reforms including maximized use of AI, improved use of Sentinel, improved IRB processes, and related reforms; working with Rep. Auchincloss, Cline, Griffith, Harder, and Sen Hickenlooper offices to draft legislation. Requested related report language for these issues as well as increased use of human challenge studies and HHS integration of privacy-preserving health data discovery and search tools in FY27NDAA and FY27 Defense, L-HHS, and Ag-FDA appropriations legislation.
Prioritization of improved indoor air quality federal facilities to promote health (additional legislation on this topic). FDA reforms including maximized use of AI, improved use of Sentinel, improved IRB processes, and related reforms; working with Rep. Auchincloss, Cline, Griffith, Harder, and Sen Hickenlooper offices to draft legislation. Requested related report language for these issues as well as increased use of human challenge studies and HHS integration of privacy-preserving health data discovery and search tools in FY27NDAA and FY27 Defense, L-HHS, and Ag-FDA appropriations legislation.
Requested report language for increased use of human challenge studies and HHS integration of privacy-preserving health data discovery and search tools in FY27 L-HHS and Ag-FDA appropriations legislation.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Discussions with congressional offices, HHS, and DoD re: client and how their product and work could save lives (including how they can help with defense)
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD; potential legislation to create a SUD PRV to increase development of and access to new SUD medicines; support for the FDA Commissioners national PRV and related pathways; support for NIH high-impact clinical trials evaluating repuposed off-patent therapeutics and widely used supplements with potential CMMI involvement; support for White House and CMMI exploration of non-opioid acute pain therapeutics. Related language requests in FY27 L-HHS and Ag-FDA appropriations.
Support for HR7840 (Event Contract Enforcement Act) addressing event contracts on war, etc. (recognizing such activity as gambling, a common addictive activity).
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD; potential legislation to create a SUD PRV to increase development of and access to new SUD medicines; support for the FDA Commissioners national PRV and related pathways; support for NIH high-impact clinical trials evaluating repuposed off-patent therapeutics and widely used supplements with potential CMMI involvement; support for White House and CMMI exploration of non-opioid acute pain therapeutics. Related language requests in FY27 L-HHS and Ag-FDA appropriations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Requested related report language for these issues as well as increased use of human challenge studies and HHS integration of privacy-preserving health data discovery and search tools in FY27NDAA and FY27 Defense, L-HHS, and Ag-FDA appropriations legislation.
Requested report language for increased use of human challenge studies and HHS integration of privacy-preserving health data discovery and search tools in FY27 L-HHS and Ag-FDA appropriations legislation.
Prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Requested related report language for these issues as well as increased use of human challenge studies and HHS integration of privacy-preserving health data discovery and search tools in FY27NDAA and FY27 Defense, L-HHS, and Ag-FDA appropriations legislation.
Prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Requested related report language for these issues as well as increased use of human challenge studies and HHS integration of privacy-preserving health data discovery and search tools in FY27NDAA and FY27 Defense, L-HHS, and Ag-FDA appropriations legislation.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity, critical for disaster preparedness
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Discussions with congressional offices, HHS, and DoD re: client and how their product and work could save lives (including how they can help with defense)
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296)
Prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
Discussions with congressional offices and HHS re: client and how their product and work could save lives
Discussions with congressional offices, HHS, and DoD re: client and how their product and work could save lives (including how they can help with defense)
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries.
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296).
Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language; H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA, S.2296)
House and Senate FY26 appropriations bills (L-HHS, H.R.5304, S.2587) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
Discussions with congressional offices and HHS re: client and how their product and work could save lives
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language, Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language: Ag-FDA S.2256, H.R. 4121); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines. Support for the FDA Commissioners announced national PRV.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
House and Senate FY26 appropriations bills (L-HHS) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health
Pandemic and All-Hazards Preparedness and Response Act (PAHPA) and Prescription Drug User Fee Act (PDUFA) and House and Senate FY26 Ag-FDA (S.2256, H.R. 4121), L-HHS appropriations bills (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA); FDA reforms including maximized use of AI (pursuit of related congressional support letters as well). Support for Sen. Cassidy's anticipated HEP-C elimination legislation (including specifically clinical trial research). Communication with congressional offices re: enabling greater use of human challenge studies. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Discussions with the HHS and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
House and Senate FY26 appropriations bills (Ag-FDA: S.2256, H.R. 4121) and NDAA S. 2296 (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health
House and Senate FY26 appropriations bills (Ag-FDA: S.2256, H.R. 4121) and NDAA S. 2296 (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 defense appropriations (H.R.4016) requests to ensure adequate funding to finalize development and distribution
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY26 defense appropriations requests to ensure adequate funding to finalize development and distribution
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Pandemic and All-Hazards Preparedness and Response Act (PAHPA) and Prescription Drug User Fee Act (PDUFA) and House and Senate FY26 appropriations bills (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA); FDA reforms including maximized use of AI. Support for Sen. Cassidy's anticipated HEP-C elimination legislation. Support for Sen. Cassidy's anticipated HEP-C elimination legislation (including specifically clinical trial research). Communication with congressional offices re: enabling greater use of human challenge studies. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Discussions with the HHS and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
Pandemic and All-Hazards Preparedness and Response Act (PAHPA) and Prescription Drug User Fee Act (PDUFA) and House and Senate FY26 appropriations bills (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA); FDA reforms including maximized use of AI. Support for Sen. Cassidy's anticipated HEP-C elimination legislation. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Discussions with the HHS and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
House and Senate FY26 appropriations bills and NDAA (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health
House and Senate FY26 appropriations bills and NDAA (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health
House and Senate FY26 appropriations bills and NDAA (and report language) and interactions with HHS officials to ensure prioritization of improved indoor air quality in military and other federal facilities and by Medicare and Medicaid providers to promote health
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Pandemic and All-Hazards Preparedness and Response Act (PAHPA) and Prescription Drug User Fee Act (PDUFA) and House and Senate FY26 appropriations bills (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA); FDA reforms including maximized use of AI. Support for Sen. Cassidy's anticipated HEP-C elimination legislation. Support for Sen. Cassidy's anticipated HEP-C elimination legislation (including specifically clinical trial research). Communication with congressional offices re: enabling greater use of human challenge studies. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Discussions with the HHS and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
Pandemic and All-Hazards Preparedness and Response Act (PAHPA) and Prescription Drug User Fee Act (PDUFA) and House and Senate FY26 appropriations bills (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA); FDA reforms including maximized use of AI. Support for Sen. Cassidy's anticipated HEP-C elimination legislation. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Discussions with the HHS and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
House and Senate FY26 appropriations bills and NDAA (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health
House and Senate FY26 appropriations bills and NDAA (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines.
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD (including support letters and FY26 appropriations language); potential legislation to create a SUD PRV to increase development of and access to new SUD medicines.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
Pandemic and All-Hazards Preparedness and Response Act (PAHPA) and Prescription Drug User Fee Act (PDUFA) and House and Senate FY26 appropriations bills (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA); FDA reforms including maximized use of AI. Support for Sen. Cassidy's anticipated HEP-C elimination legislation. Support for Sen. Cassidy's anticipated HEP-C elimination legislation (including specifically clinical trial research). Communication with congressional offices re: enabling greater use of human challenge studies. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Discussions with the HHS and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
Pandemic and All-Hazards Preparedness and Response Act (PAHPA) and Prescription Drug User Fee Act (PDUFA) and House and Senate FY26 appropriations bills (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA); FDA reforms including maximized use of AI. Support for Sen. Cassidy's anticipated HEP-C elimination legislation. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Discussions with the HHS and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Discussions with / outreach to (and/or preparation for such outreach) DoD, VA, Congressional offices, and HHS officials re: potential avenues to increase GLP-1 access to veterans and others as a method of substance use disorder treatment and other potential strategies for increasing innovation and the development of improved addiction medicines
Discussions with / outreach to (and/or preparation for such outreach) DoD, Congressional offices, and HHS officials re: potential avenues to increase GLP-1 access to veterans and others as a method of substance use disorder treatment and other potential strategies for increasing innovation and the development of improved addiction medicines (including the medical countermeasure priority review voucher included in the first Dec 2024 Continuing Resolution draft)
Filing targets: Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA)
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with congressional letter(s) of support to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines Discussions with the WH, HHS, and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and strengthen interagency relationships for national security and emerging pathogen / pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with the WH, HHS, and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives Interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness (HR9027, HR9029; S4638; S4690). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with congressional letter(s) of support to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines Discussions with the WH, HHS, and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Discussions with / outreach to Congressional offices and HHS officials re: potential avenues to increase GLP-1 access to veterans and others as a method of substance use disorder treatment and other potential strategies for increasing resources devoted to the development of improved addiction medicines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA)
Filing targets: Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
House and Senate FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and strengthen interagency relationships for national security and emerging pathogen / pandemic preparedness (HR9027, HR9029; S4638; S4690). To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives Interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Exploring how to collaborate with the federal government (such as VA and DoD) to advance better medical therapies for addiction
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with pursuing a letter of support from the Senate to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Filing targets: Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); FY24 & FY25 appropriations to ensure adequate resources for HHS for pandemic preparedness. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with a letter of support to HHS, encouraging the establishment of an emerging pathogen preparedness program through the FDA Assistance with a letter of support from the US House (and pursuing one from the Senate) to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines . To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with a letter of support to HHS, encouraging the establishment of an emerging pathogen preparedness program through the FDA. To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with a letter of support to HHS, encouraging the establishment of an emerging pathogen preparedness program through the FDA. To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA). Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with a letter of support to HHS, encouraging the establishment of an emerging pathogen preparedness program through the FDA. To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA). Assistance with a letter of support to HHS, encouraging the establishment of an emerging pathogen preparedness program through the FDA. To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE